QIM
EPZM

Quantitative Investment Management’s Epizyme, Inc EPZM Stock Holding History

Quantitative Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,586
Closed -$412K – 737
2020
Q1 		$412K Buy
+26,586
New +$571K 0.05% 356

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Quantitative Investment Management's EPZM Position: Q2 2020 in Review

Quantitative Investment Management sold out of Epizyme, Inc (EPZM) in Q2 2020, closing a stake of 26,586 shares — an estimated $412K sold.

Quantitative Investment Management first reported a position in EPZM in Q1 2020 and held it in 1 quarter. The position peaked at $412K in Q1 2020. 160 funds tracked by Wall St. Rank hold EPZM as of Q2 2020.

  • Quantitative Investment Management reported no remaining Epizyme, Inc position as of Q2 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 26,586 Epizyme, Inc shares in Q2 2020, an estimated $412K.
  • Quantitative Investment Management first reported a position in Epizyme, Inc in Q1 2020 and held it in 1 quarter.
  • Quantitative Investment Management's Epizyme, Inc position peaked at $412K in Q1 2020.
  • 160 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2020.

Based on Quantitative Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.